Experimental cell shot aims to tame lupus kidney Flare-Ups
NCT ID NCT07412210
First seen Mar 06, 2026 · Last updated May 13, 2026 · Updated 6 times
Summary
This early-phase trial tests a new cell therapy (ES-NK cells) in 5 to 9 people with severe lupus kidney disease that hasn't responded to standard treatments. The goal is to see if the therapy is safe and can help control the disease. Participants will receive one of three dose levels, and the study will monitor side effects and kidney remission.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHENLATOSUS NEPHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.